This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Atenolol and Chlorthalidone

Read time: 1 mins
Marketing start date: 21 Dec 2024

Summary of product characteristics


Effective Time

20220802

Version

3

Spl Product Data Elements

Atenolol and Chlorthalidone Atenolol and Chlorthalidone ATENOLOL ATENOLOL CHLORTHALIDONE CHLORTHALIDONE ANHYDROUS CITRIC ACID CROSCARMELLOSE SODIUM MAGNESIUM STEARATE SILICON DIOXIDE STARCH, CORN WHITE TO OFF WHITE ROUND 11;67 Atenolol and Chlorthalidone Atenolol and Chlorthalidone ATENOLOL ATENOLOL CHLORTHALIDONE CHLORTHALIDONE ANHYDROUS CITRIC ACID CROSCARMELLOSE SODIUM MAGNESIUM STEARATE SILICON DIOXIDE STARCH, CORN WHITE TO OFF WHITE ROUND 11;68

Application Number

ANDA210028

Brand Name

Atenolol and Chlorthalidone

Generic Name

Atenolol and Chlorthalidone

Product Ndc

70771-1373

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1372-1 Atenolol and Chlorthalidone Tablets, USP 50 mg/25 mg Rx only 100 Tablets NDC 70771-1373-1 Atenolol and Chlorthalidone Tablets, USP 100 mg/25 mg Rx only 100 Tablets Atenolol and Chlorthalidon Tablets, USP Atenolol and Chlorthalidon Tablets, USP

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.